Which pregnancy category is Fenofibrate classified under?

Fenofibrate is classified under "No category" when it comes to pregnancy risk categories. This classification denotes that there is insufficient data to adequately assess the drug's safety for use during pregnancy. Unlike drugs that fall into Category A, B, or C, which indicate varying levels of risk based on available studies, the absence of a designated category means that there isn't enough research to make a determination regarding its effects on pregnant individuals or developing fetuses.

Fenofibrate is primarily used to manage cholesterol levels, and while the drug may be prescribed for certain conditions, the lack of clear data on its safety during pregnancy leads to caution in its use. Healthcare providers must weigh the potential benefits against any unknown risks when considering this medication for pregnant patients. Consequently, this placement reflects the importance of careful assessment and individualized treatment in this sensitive population.